NIFTY 23165.70 BANK 50827.50

Jagsonpal Pharmaceuticals Limited
Share Price Target & Analysis

NSE:JAGSNPHARM

215.44

VWAP

217.9

Open

217.2

Close

220.28

High

211.21

Low

328.04

52 Week High

217.04 ⇩
-0.16 (-0.07%)

JAGSNPHARM

(PHARMA)
49.1% Momentum

Turnaround Potential

110

52 Week Low

7.88

EPS

45.98

PE

7.31

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: JAGSNPHARM Share Price Financial Analysis & Valuation

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 423.1 (in Cr). Total number of free float shares are 2.6 (in Lacs). Jagsonpal Pharmaceuticals Limited is listed on NSE with Exchange ID - INE048B01035 and trading code is NSE:JAGSNPHARM with short name JagsonpalPharma.

In the past 1 year, Jagsonpal Pharmaceuticals Limited has declared an equity dividend of Rs 4 per share. At the current share price of JAGSNPHARM at Rs 217.04, this results in a dividend yield of 1.84 %.

As per the Fundamental Analysis of NSE:JAGSNPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JAGSNPHARM underlying value and future prospects. All of this data is available in JAGSNPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:JAGSNPHARM, it is clearly understood that JAGSNPHARM is Economical performer in terms of earnings and profit margins with an EPS of 7.88. NSE:JAGSNPHARM book value per share as of today is 29.69. The current price to book ratio for JAGSNPHARM as of Apr 02, 2025 is 7.31.

Valuation of the Stock: The current valuation of JAGSNPHARM stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JAGSNPHARM whether to BUY this stock at current valuation. The delivery percentage of JAGSNPHARM is 34.76% is very crucial parameter which shows that 34.76% investors are anticipating that the price of JAGSNPHARM share should go up with VWAP at 215.44.

Now, the main question is whether to BUY or SELL, NSE:JAGSNPHARM at current valuation.
As per latest Analysis No. #725:-

⇑ STRONG BUY JAGSNPHARM if All Greens

⇗ BUY JAGSNPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD JAGSNPHARM (With Stop Loss) if only 1 Green

⇘ SELL JAGSNPHARM if NO Green Indicator

NSE: JAGSNPHARM Share Price Today (Apr 02, 2025)

(Jagsonpal Pharmaceuticals Limited Daily Analysis on the basis of JAGSNPHARM Intraday Graph & Trend)

Jagsonpal Pharmaceuticals Limited share price moved Down by -0.07% from its previous close of Rs 217.2. JAGSNPHARM stock last traded price is 217.04. JAGSNPHARM share price trend is Down with a total of 88625 stocks traded till now. It has touched an intraday high of Rs 220.28 and an intraday low of Rs 211.21. The JAGSNPHARM trading at 217.04, Down by Rs. -0.16, or -0.07 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down.

NSE: JAGSNPHARM Share Price Tomorrow Prediction

(Jagsonpal Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited share price moved Down by -0.07%. JAGSNPHARM share price short term trend is Down. It suggests that JAGSNPHARM Share Price for Tomorrow remains the same with VWAP at 215.44 will be treated as stop loss for intraday traders. Jagsonpal Pharmaceuticals Limited Long term investors can follow the JAGSNPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: JAGSNPHARM

JAGSNPHARM Share Price Today

 217.04

JAGSNPHARM Share Price Target Prediction for 2025 ^

 115.3 - 233.1

JAGSNPHARM Share Price Target Prediction for 2026*^

 233.1 - 351.2

JAGSNPHARM Share Price Target Prediction for 2027*^

 351.2 - 375.8

JAGSNPHARM Share Price Target Prediction for 2028*^

 395

JAGSNPHARM Share Price Target Prediction for 2029*^

 406

JAGSNPHARM Share Price Target Prediction for 2030*^

 442
JAGSNPHARM Current Book Value 2024
29.5

*Jagsonpal Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JAGSNPHARM share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

JAGSNPHARM Technical Analysis

Candlestick Pattern: @214.25

JAGSNPHARM Moving Averages

BUY (2) NEUTRAL (0) SELL (12)
MA Simple Action S1 Expo Action E2
MA_5 216.3 SELL 218.24 SELL
MA_12 231.15 SELL 226.39 SELL
MA_20 238.01 SELL 230.41 SELL
MA_32 232.02 SELL 234.6 SELL
MA_50 240.6 SELL 235.65 SELL
MA_100 240.86 SELL 229.06 SELL
MA_200 190.64 BUY 203.66 BUY

JAGSNPHARM Trend Oscillators

BUY (0) NEUTRAL (1) SELL (3)
Trend Oscillators Value Action
Bollinger Bands 238.01 Downtrend
MACD -2.93 SELL
ADX 18.92 NO or Weak Trend
DMI (+/-) 13.68 / 23.24 Downtrend

JAGSNPHARM Momentum Oscillators

BUY (1) NEUTRAL (8) SELL (3)
Momentum Oscillators Value Action
RSI 42.25 Neutral
STOCHASTIC_K (Fast) 37.97 Neutral
STOCHASTIC_D (Slow) 38.34 Neutral
CCI -89.54 Neutral
PSAR 255.01 SELL
TRUE RANGE 9.61 Neutral
ATR 20.24 Neutral
WILLIAMS R -91.4 Oversold
TRIX 0 Neutral
STOCHASTIC RSI K 18.94 Oversold
STOCHASTIC RSI D 52.89 Neutral
MOMENTUM 0.95 BUY

JAGSNPHARM Last 1 Year Trend

Duration Value
1 Year 71.73%
3 Months -20.18%
1 Month 0.45%
1 Week -2.95%

JAGSNPHARM Technical Analysis Summary

Updated on 2025-02-24
Action Overall (%)
BUY 10%
NEUTRAL / HOLD 30%
SELL 60%

Most popular Questions & Answers about JAGSNPHARM


Jagsonpal Pharmaceuticals Limited stock last traded price is 217.04. JAGSNPHARM share price moved Down by -0.07% from its previous close of Rs 217.2.

Jagsonpal Pharmaceuticals Limited share price trend is Down with a total of 88625 stocks traded till now. It has touched an intraday high of Rs 331.3204 and an intraday low of Rs 211.21. The JAGSNPHARM trading at 217.04, Down by Rs. -0.16, or -0.07 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down and the Stop Loss will be around 215.44.

The market cap of Jagsonpal Pharmaceuticals Limited is ₹423.1 (in Cr) as of Apr 01, 2025.

The current price to earning ratio for Jagsonpal Pharmaceuticals Limited as of Apr 01, 2025 is 45.98.

The current price to book ratio for Jagsonpal Pharmaceuticals Limited as of Apr 01, 2025 is 7.31.

The highest price of Jagsonpal Pharmaceuticals Limited stock is ₹328.04 in the last 52-week.

The lowest price of Jagsonpal Pharmaceuticals Limited stock is ₹110 in the last 52-week.

Jagsonpal Pharmaceuticals Limited share trading at ₹217.04, Down by Rs. -0.16, or -0.07 percent which suggests that most of the traders are anticipating that the price of JAGSNPHARM share should go Down.

In 2023, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹115.3 on downside and ₹233.1 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on current financial year earings of the company.

In 2024, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹233.1 on downside and ₹351.2 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.

In 2025, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹351.2 on downside and ₹375.8 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹406 Jagsonpal Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JAGSNPHARM.

The price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares moved by -0.07%. The short-term trend for JAGSNPHARM share price is Down. It implies that the share price of JAGSNPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 215.44 as a stop loss. Investors with a long-term outlook can track JAGSNPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of JAGSNPHARM stock is 94.5. Compared to the current market price of 217.04 INR, the JAGSNPHARM stock is Overvalued by 56.5%.

As per the fundamental analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM), it is of Economical quality in terms of earnings and profit margins with an EPS of 7.88. Jagsonpal Pharmaceuticals Limited book value per share as of today is 29.69. The current price to book ratio for JAGSNPHARM as of Apr 02, 2025 is 7.31.


NSE:JAGSNPHARM News & Other Useful Information about JAGSNPHARM Share Price


Peer Comparison of NSE: JAGSNPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1698.30 13.13 98.33
DIVISLAB 5545.00 78.09 513.62
MEDICAMEQ 493.55 7.98 173.4
CIPLA 1447.00 58.33 360.74
DRREDDY 1150.00 62.12 322.46
PGHH 15925.70 189.8 324.25
TORNTPHARM 3180.90 53.89 222.38
BIOCON 339.10 5.01 90.7
LUPIN 1955.40 67.15 481.38
ALKEM 4835.55 194.78 984.46
Updated at: 01 Apr 2025 15:43

Feel free to contact us, in case of any queries.

SITEMAP 2918
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2340.00 24.20 (1.04%) | ADANIGREEN 923.00 -25.65 (-2.7%) | ADANIPORTS 1176.50 -6.45 (-0.55%) | ADANITRANS 1010.05 -18.55 (-1.8%) | AMBUJACEM 530.00 -8.35 (-1.55%) | APOLLOHOSP 6632.30 16.10 (0.24%) | ASIANPAINT 2316.70 -23.95 (-1.02%) | ATGL 593.70 -8.90 (-1.48%) | AUROPHARMA 1134.15 -26.35 (-2.27%) | AXISBANK 1085.20 -16.80 (-1.52%) | BAJAJ-AUTO 7975.00 96.15 (1.22%) | BAJAJFINSV 1941.90 -65.45 (-3.26%) | BAJFINANCE 8719.35 -226.25 (-2.53%) | BALKRISIND 2523.55 -31.25 (-1.22%) | BANDHANBNK 149.55 3.27 (2.24%) | BANKBARODA 228.58 0.05 (0.02%) | BEL 292.00 -9.32 (-3.09%) | BERGEPAINT 494.00 -6.20 (-1.24%) | BHARTIARTL 1723.60 -9.80 (-0.57%) | BIOCON 339.10 -2.60 (-0.76%) | BOSCHLTD 27884.10 -474.35 (-1.67%) | BPCL 285.70 7.23 (2.6%) | BRITANNIA 4905.70 -31.20 (-0.63%) | CADILAHC 1100.00 -15.15 (-1.36%) | CIPLA 1447.00 4.80 (0.33%) | COALINDIA 398.00 -0.20 (-0.05%) | COLPAL 2350.00 -39.80 (-1.67%) | DABUR 497.60 -8.90 (-1.76%) | DIVISLAB 5545.00 -230.45 (-3.99%) | DLF 662.50 -18.00 (-2.65%) | DMART 4016.00 -67.20 (-1.65%) | DRREDDY 1150.00 5.80 (0.51%) | EICHERMOT 5301.15 -46.55 (-0.87%) | GAIL 186.15 3.11 (1.7%) | GLAND 1554.00 -38.40 (-2.41%) | GODREJCP 1146.80 -12.45 (-1.07%) | GRASIM 2612.05 0.90 (0.03%) | GUJGASLTD 409.80 -2.55 (-0.62%) | HAVELLS 1500.00 -28.90 (-1.89%) | HCLTECH 1534.50 -58.00 (-3.64%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 3980.00 -33.90 (-0.84%) | HDFCBANK 1769.90 -58.30 (-3.19%) | HDFCLIFE 693.00 7.30 (1.06%) | HEROMOTOCO 3762.05 39.10 (1.05%) | HINDALCO 663.50 -18.95 (-2.78%) | HINDUNILVR 2237.00 -21.85 (-0.97%) | HINDZINC 453.55 -8.35 (-1.81%) | ICICIBANK 1318.15 -30.20 (-2.24%) | ICICIGI 1796.00 3.15 (0.18%) | ICICIPRULI 571.10 6.75 (1.2%) | INDIGO 5036.00 -79.35 (-1.55%) | INDUSINDBK 682.70 32.85 (5.06%) | INDUSTOWER 352.25 17.95 (5.37%) | INFY 1530.20 -40.45 (-2.58%) | IOB 37.69 -1.28 (-3.28%) | IOC 131.45 3.75 (2.94%) | ITC 406.60 -3.15 (-0.77%) | JSWSTEEL 1060.00 -3.20 (-0.3%) | KOTAKBANK 2144.30 -26.90 (-1.24%) | LT 3438.30 -54.00 (-1.55%) | LTI 6149.30 78.10 (1.29%) | LUPIN 1955.40 -72.55 (-3.58%) | M&M 2640.00 -25.80 (-0.97%) | MARICO 650.00 -1.65 (-0.25%) | MARUTI 11455.25 -66.90 (-0.58%) | MCDOWELL-N 1485.00 -14.35 (-0.96%) | MOTHERSUMI 187.83 -5.36 (-2.77%) | MUTHOOTFIN 2328.00 -54.90 (-2.3%) | NAUKRI 6787.60 -393.80 (-5.48%) | NESTLEIND 2234.90 -15.85 (-0.7%) | NMDC 69.77 0.88 (1.28%) | NTPC 352.95 -4.65 (-1.3%) | ONGC 248.35 1.97 (0.8%) | PEL 989.05 1.20 (0.12%) | PIDILITIND 2829.45 -19.85 (-0.7%) | PIIND 3450.40 22.20 (0.65%) | PNB 96.49 0.36 (0.37%) | POWERGRID 289.10 -1.25 (-0.43%) | RELIANCE 1254.00 -21.10 (-1.65%) | SAIL 116.88 1.70 (1.48%) | SBICARD 860.00 -21.10 (-2.39%) | SBILIFE 1542.30 -5.55 (-0.36%) | SBIN 771.25 -0.25 (-0.03%) | SHREECEM 30081.00 -421.95 (-1.38%) | SIEMENS 5229.00 -46.35 (-0.88%) | SRF 2879.50 -59.65 (-2.03%) | SUNPHARMA 1698.30 -36.40 (-2.1%) | TATACONSUM 992.40 -9.50 (-0.95%) | TATAMOTORS 672.00 -2.45 (-0.36%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 153.25 -0.99 (-0.64%) | TCS 3556.45 -49.70 (-1.38%) | TECHM 1396.50 -21.75 (-1.53%) | TITAN 2988.45 -74.90 (-2.45%) | TORNTPHARM 3180.90 -47.05 (-1.46%) | ULTRACEMCO 11386.80 -122.75 (-1.07%) | UPL 634.50 -1.75 (-0.28%) | VEDL 457.25 -6.15 (-1.33%) | WIPRO 262.25 0.00 (0%) |